Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats.

scientific article published in January 2006

Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/3-211-30714-1_29
P698PubMed publication ID16671440

P2093author name stringT Maeda
T Mori
Y Katayama
T Kawamata
Y Shigemori
P921main subjectblood–brain barrierQ221694
P304page(s)130-133
P577publication date2006-01-01
P1433published inActa Neurochirurgica. SupplementumQ15750154
P1476titleMatrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats
P478volume96

Reverse relations

cites work (P2860)
Q34422275Ablation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice
Q90098730Assessment of recombinant tissue plasminogen activator (rtPA) toxicity in cultured neural cells and subsequent treatment with poly-arginine peptide R18D
Q35146718Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury.
Q89612190Basic Fibroblast Growth Factor (bFGF) Protects the Blood-Brain Barrier by Binding of FGFR1 and Activating the ERK Signaling Pathway After Intra-Abdominal Hypertension and Traumatic Brain Injury
Q87870397Blood brain barrier (BBB)-disruption in intracortical silicon microelectrode implants
Q48382130Blood-brain barrier permeability is positively correlated with cerebral microvascular perfusion in the early fluid percussion-injured brain of the rat.
Q38196884Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia
Q38826051Chloride Dysregulation, Seizures, and Cerebral Edema: A Relationship with Therapeutic Potential
Q37730929Colibactin Contributes to the Hypervirulence of pks+ K1 CC23 Klebsiella pneumoniae in Mouse Meningitis Infections.
Q30985506Dietary Docosahexaenoic Acid Improves Cognitive Function, Tissue Sparing, and Magnetic Resonance Imaging Indices of Edema and White Matter Injury in the Immature Rat after Traumatic Brain Injury
Q46492590Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug Development.
Q33702239Effects of aging on blood brain barrier and matrix metalloproteases following controlled cortical impact in mice.
Q33553427Efficacy of a metalloproteinase inhibitor in spinal cord injured dogs
Q37393237Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury
Q47407286Exposure to traffic-generated air pollutants mediates alterations in brain microvascular integrity in wildtype mice on a high-fat diet
Q64230027FGF21 Protects Against Hypoxia Injury Through Inducing HSP72 in Cerebral Microvascular Endothelial Cells
Q30570065Fish oil improves motor function, limits blood-brain barrier disruption, and reduces Mmp9 gene expression in a rat model of juvenile traumatic brain injury
Q28972580Fixed negative charge and the Donnan effect: a description of the driving forces associated with brain tissue swelling and oedema
Q36750801Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic stroke
Q53074197Glibenclamide produces region-dependent effects on cerebral edema in a combined injury model of traumatic brain injury and hemorrhagic shock in mice.
Q40111896Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies
Q26766038Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke
Q38612271Inhibition of acetylcholinesterase modulates NMDA receptor antagonist mediated alterations in the developing brain
Q47851530Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment
Q61796951Japanese encephalitis virus neuropenetrance is driven by mast cell chymase
Q36079895MT5-MMP, ADAM-10, and N-cadherin act in concert to facilitate synapse reorganization after traumatic brain injury
Q36123018Matrix Metalloproteinase Expression in Contusional Traumatic Brain Injury: A Paired Microdialysis Study
Q41230899Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice
Q36761698Matrix metalloproteinase-9 deficiency leads to prolonged foreign body response in the brain associated with increased IL-1beta levels and leakage of the blood-brain barrier
Q48111112Matrix metalloproteinases 2 and 9 fail to influence drug-induced neuroapoptosis in developing rat brain
Q37733211Matrix metalloproteinases and neurotrauma: evolving roles in injury and reparative processes
Q49827436Mechanical disruption of the blood-brain barrier following experimental concussion
Q40112481Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases
Q48113339Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift
Q57811980Neuroinflammation, oxidative stress, and blood-brain barrier (BBB) disruption in acute Utah electrode array implants and the effect of deferoxamine as an iron chelator on acute foreign body response
Q33657719Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1.
Q26768672New Prognostic Biomarkers in Patients With Traumatic Brain Injury
Q47787773Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders.
Q38459572Pathogenesis of brain edema and investigation into anti-edema drugs
Q57170806Pathophysiology and treatment of cerebral edema in traumatic brain injury
Q39008879Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides
Q41413177Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells
Q35589875Preservation of the blood brain barrier and cortical neuronal tissue by liraglutide, a long acting glucagon-like-1 analogue, after experimental traumatic brain injury
Q34489690Resveratrol neuroprotection in stroke and traumatic CNS injury
Q35007289Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor
Q38626384Role of Matrix Metalloproteinases in the Pathogenesis of Traumatic Brain Injury
Q54977421Selective Toll-Like Receptor 4 Antagonists Prevent Acute Blood-Brain Barrier Disruption After Subarachnoid Hemorrhage in Mice.
Q44246688Single nucleotide polymorphisms in the angiogenic and lymphangiogenic pathways are associated with lymphedema caused by Wuchereria bancrofti
Q48429410Sulfonylurea Receptor-1: A Novel Biomarker for Cerebral Edema in Severe Traumatic Brain Injury
Q59807366Sulforaphane from Cruciferous Vegetables: Recent Advances to Improve Glioblastoma Treatment
Q37692206The Immunomodulatory Effects of Plant Extracts and Plant Secondary Metabolites on Chronic Neuroinflammation and Cognitive Aging: A Mechanistic and Empirical Review
Q90070819The Medical Management of Cerebral Edema: Past, Present, and Future Therapies
Q37154481The potential utility of blood-derived biochemical markers as indicators of early clinical trends following severe traumatic brain injury
Q33699683Tobacco smoke: a critical etiological factor for vascular impairment at the blood-brain barrier
Q33649452Traumatic brain injury results in disparate regions of chondroitin sulfate proteoglycan expression that are temporally limited

Search more.